ArticleFrontiers in medicine2025
Pathophysiological mechanisms of functional dyspepsia: a narrative review.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Planetary Health Diet Adherence and Medication Use in Older Adults with Chronic Kidney Disease: A Cross-Sectional Study.Geriatrics (Basel, Switzerland) · 2026Article
- Electroacupuncture alleviates functional dyspepsia by modulating the vagus nerve to regulate duodenal microbiota and suppress TWEAK/Fn14/NF-κB and arachidonic acid metabolic pathways.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Functional dyspepsia (FD) is a common gastrointestinal disorder with a global prevalence of about 40%. Its pathogenesis is multifactorial and not fully understood, which complicates diagnosis and treatment. Advances in research have improved understanding of the mechanisms underlying FD, offering opportunities to refine diagnosis and therapy. Summary: FD presents with upper abdominal discomfort, bloating, belching, and nausea, in the absence of structural disease. Its heterogeneous pathogenesis involves impaired gastric accommodation, delayed gastric emptying, mucosal immune activation, microbiota imbalance, altered neuroendocrine and sensory processing, and psychosocial influences. While treatment options have expanded, challenges remain due to overlapping symptoms and variability among patients. Key messages: FD is associated with abnormalities in gastrointestinal motility, immune responses, brain-gut interactions, and psychosocial factors. Recognizing its heterogeneity is crucial for developing individualized management strategies. Better characterization of patient subtypes may improve diagnostic accuracy, guide therapy, and ultimately enhance clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.